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Abstract
Background: Central cord syndrome (CCS) is considered the most common incomplete spinal cord injury (SCI).
Independent ambulation was achieved in 87-97% in young patients with CCS but no gait analysis studies have
been reported before in such pathology. The aim of this study was to analyze the gait characteristics of subjects
with CCS and to compare the findings with a healthy age, sex and anthropomorphically matched control group
(CG), walking both at a self-selected speed and at the same speed.
Methods: Twelve CCS patients and a CG of twenty subjects were analyzed. Kinematic data were obtained
using a three-dimensional motion analysis system with two scanner units. The CG were asked to walk at two
different speeds, at a self-selected speed and at a slower one, similar to the mean gait speed previously
registered in the CCS patient group. Temporal, spatial variables and kinematic variables (maximum and
minimum lower limb joint angles throughout the gait cycle in each plane, along with the gait cycle instants
of occurrence and the joint range of motion - ROM) were compared between the two groups walking at
similar speeds.
Results: The kinematic parameters were compared when both groups walked at a similar speed, given that there
was a significant difference in the self-selected speeds (p < 0.05). Hip abduction and knee flexion at initial contact,
as well as minimal knee flexion at stance, were larger in the CCS group (p < 0.05). However, the range of knee and
ankle motion in the sagittal plane was greater in the CG group (p < 0.05). The maximal ankle plantar-flexion values
in stance phase and at toe off were larger in the CG (p < 0.05).
Conclusions: The gait pattern of CCS patients showed a decrease of knee and ankle sagittal ROM during level
walking and an increase in hip abduction to increase base of support. The findings of this study help to improve
the understanding how CCS affects gait changes in the lower limbs.
Background
Incomplete spinal cord injury (SCI), comprising about
30% of cases, is the most frequent form of SCI [1]. The
c e n t r a lc o r ds y n d r o m e( C C S )i sc o n s i d e r e dt h em o s t
common incomplete SCI syndrome with a reported inci-
dence varying from 15.7% to 25% [2]. CCS was first
described by Schneider as a condition that is associated
with sacral sparing and it is characterized by motor weak-
ness that affects more the upper extremities than the
lower limbs [3]. Independent ambulation was achieved in
87-97% in younger patients compared to 31-41% in
patients older than 50 years at the time of injury [4].
The effect that the level of the lesion has on spasticty
during walking has been studied in SCI patients [5], as
have the changes in gait in patients with cervical myelo-
pathy following therapeutic interventions [6], and even
the gait of children and adolescents with SCI [7]. How-
ever, there are few studies that have focused on the bio-
mechanics of gait in patients with CCS. To date,
comparative biomechanical data has only been obtained
in such patients for gait aided by one or two walking
sticks [8]. However, the need to use biomechanical ana-
lyses to evaluate this patient group has been already
emphasised [7,9]. The specific walking disorders occur-
ring after incomplete SCI have been scarcely described
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bances in the gait patterns of children and adolescents
with SCI underscoring the importance of gait analysis as
a tool to take therapeutic decisions, such as the pre-
scription of orthosis or a surgical procedure, and to
evaluate the patient during treatment or after surgical
intervention [7].
Walking problems following CCS and other incom-
plete SCI syndromes have led to a wave of interest in
using specific treatments, such as botulinum toxin type
A [10] in combination with splinting to correct gait pat-
terns. Different gait analyses have been carried out in
several neuro-motor disorders [6,11,12]. These studies
provide the basis to describe the type of gait distur-
bances that can be expected in these groups of patients
and serve to define a rehabilitation therapy with realistic
goals. In this context, the aim of the present study is to
analyze the gait characteristics of subjects with CCS in
order to quantify their gait pattern, and to compare
these findings with a healthy age and sex matched con-
trol group using three-dimensional gait analysis walking
at a self selected speed and at similar speed in both
groups. The hypothesis tested was that kinematic values
would in most cases be significantly different to
those from a normal population, not only in the spatial-
temporal parameters of gait but also in the joint
motion. Accordingly, the findings obtained from the
kinematic analysis of gait performed here should
help to define the treatment necessary to resolve the
problems detected.
Methods
Subjects
Twelve patients suffering from CCS participated in the
experiments. Their average age was 42.6 ± 17.3 years
(range, 21-61 years), height 162 ± 0.1 cm (range, 146-
186 cm) and weight 68.7 ± 15.6 kg (range, 40-89 kg:
Table 1). The inclusion criteria were:
￿ Age range between 18 and 65 years.
￿ Clinical diagnosis of CCS: Patients with Spinal
Cord Injury that displayed motor weakness affecting
the upper limbs more than the lower limbs [3].
￿ Absence of previous history of locomotor or neu-
rologic abnormality.
￿ Injury at least 12 months old.
The exclusion criteria were:
- Passive restriction of the joints.
- A diagnosis of any other neurological or orthopae-
dic disease that could affect locomotion.
Table 1 Clinical characteristics of both groups
Variable CCS group (n = 12) Control group (n = 20)
Sex (men)
† 8 (67) 12 (60)
Age (years)* 42.58 (17.3) 34.50 (9.8)
Height (cm)* 162 (13.44) 167 (8.08)
Weight (kg) * 68.7 (15.6) 65.9 (10.8)
Time since injury (months)* 16.2 (15.7) NA
Age when injury (years)* 40.5 (16.4) NA
Level of injury C1
† 1 (8.3) NA
Level of injury C4
† 5 (41.6) NA
Level of injury C5
† 2 (16.6) NA
Level of injury C6
† 2 (16.6) NA
Level of injury C7
† 2 (16.6) NA
Right upper limb motor score(maximum 25)* 19.5 (3.1) 25
Left upper limb motor score (maximum 25)* 19.6 (3.5) 25
Right lower limb motor score (maximum 25)* 21.7 (3.2) 25
Left lower limb motor score (maximum 25)* 21.4 (3.9) 25
Upper Limb Motor Score (maximum 50) 33.83 (4.41) 50
Lower Limb Motor Score (maximum 50) 42.33 (5.19) 50
Average between upper limb and lower limb motor score. 8.50 NA
Ashworth score* 1.21 (0.2) NA
WISCI II
† 20 (100) NA
TUG (seconds)* 17.1 (6.9) NA
10MWT (seconds)* 17.4 (6.7) NA
†Data are expressed as number (%) for categorical variables.
*Data are expressed as mean (SD) for continuous variables.
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Page 2 of 10- A diagnosis of any other disease associated with
memory, concentration and/or visual deficits.
- Failure to comply with any of the criteria for
inclusion.
Data from CCS patients were compared to an age, sex
and anthropomorphically-matched healthy control group
(CG) that included 20 subjects (12 male and 8 female).
Their average age was 34.5 ± 9.8 years (range, 22-65),
height, 167 ± 0.1 cm (range 157-184 cm) and weight 65.9
± 10.8 kg (range 51-95 kg). All the participants provided
informed consent prior to be included in this study and
the study design was approved by local ethics committee.
Materials
Kinematic data were recorded at 200 Hz using a three-
dimensional motion analysis system (CODA System.6,
Charnwood Dynamics, Ltd, UK) with two scanner units.
Eleven active markers were placed on each lower limb
(Figures 1 and 2) following a model described previously
[8]. The recording was obtained simultaneously from
both sides.
Data collection
All CCS patients were asked to walk barefoot along a
10-m long walkway at a self-selected speed while
temporal-spatial and kinematic data were recorded. It
must be noted that all the kinematic parameters of gait
depend on the speed [13]. Therefore, the CG were
asked to walk at two different speeds, at a self-selected
speed and at a slower one that was similar to the mean
gait speed registered previously in the CCS patient
group. Considering that the average speed of the
patients was 0.7 m/s (SD = 0.2), the slow speed trials of
the healthy controls were only included when the walk-
ing speed were between 0.7 m/s and 1.2 m/s [13]. The
subjects in the control group were helped to walk more
slowly with vocal commands.
Five valid trials were collected for each patient at a
self selected speed and for CG at a self selected speed
and at slow speed to reduce intrasubject variability. All
the subjects were given a 1-minute rest period between
trials.
Data analysis
For each trial, a single gait cycle corresponding to the
patient’s cycle when crossing the midpoint of a 10-m
walkway was selected to ensure that the gait pattern was
free of the influence of the initial acceleration and the
final braking. The temporal-spatial variables registered
were: gait velocity, stride length, step length, stride time,
step time, strides/minute, steps/minute or cadence, and
Figure 1 Marker placement in a subject. Frontal plane.
Figure 2 Marker placement in a subject. Sagital plane.
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data included: maximum and minimum value of lower
limb joint angles throughout the gait cycle in 3 planes,
along with the gait cycle instants of occurrence and the
joint range of motion (ROM). Both groups of variables
were compared between the two groups, CCS and CG.
The data from right and left limbs were averaged. All
temporal events were expressed as gait cycle percentages
(0-100%), defined between two consecutive heel-strikes of
the same limb. The spatial parameters, speed, stride length,
a n ds t e pl e n g t hw e r en o r m a l i s e db yt h es u b j e c th e i g h t
[5,11].
Statistical analysis
For each subject, each computed parameter was calcu-
lated as the average of the values obtained in the five
trials considered. A descriptive analysis was made of the
clinical and functional variables by calculating the mean
and standard deviation of the quantitative variables and
the frequencies and percentages of the qualitative
variables.
The normality distribution was checked for all the vari-
ables using the Kolmogorov-Smirnov test. Equality of
variances was evaluated by Levene’s test. Data were ana-
lysed using several one-way ANOVA tests (CCS group/
CG group) with p = 0.05. All statistical analyses were per-
formed using SPSS 12.0 (SPSS Inc, Chicago, IL, USA).
We certify that all applicable institutional and govern-
ment regulations concerning the ethical use of human
volunteers were followed during the course of this
research.
Results
Clinical measurements
All patients had a cervical injury and they were classi-
fied as ASIA D [14]. The results of the clinical and
functional assessment scales, such as Asworth score
for spasticity measurement [15], WISCI (Walking
Index Spinal Cord Injury) [16], TUG (Time Up and
Go) [17] and 10MWT (10 Meter Walking Test) [17]
most commonly used in this type of patient are shown
in Table 1. The motor scores of both the upper limbs
and lower limbs on both sides were similar, indicating
symmetrical involvement [14], and the mean Ashworth
score was 1.21 ± 0.2, which indicates that this group of
patients does not suffer fromp r o n o u n c e ds p a s t i c i t y
[15]. None of the CCS patients needed a crutch to
walk.
Healthy control group at self selected speed versus
patients with CCS
Significant differences between both groups were
obtained in all of the temporal-spatial parameters when
walking at self-selected speed (Table 2). Given these dif-
ferences and that speed affects the kinematic para-
meters, possibly acting as a confounding factor, a
comparison was made with the kinematic data obtained
when the control subjects walked at a speed similar to
that of the CCS patients. In this way, we were sure that
the differences observed in the kinematic parameters
were not due to the speed of walking.
Healthy control group and patients with CCS at a
matched speed
a) Temporal-spatial parameters
There were no significant differences in these para-
meters (Table 2).
b) Pelvis motion
Considering the average duration of the cycle, the maxi-
mal pelvic obliquity arose later in CCS patients than in
controls, while the minimum obliquity occurred earlier
in the patients. In addition, there was a slight anterior
Table 2 Temporal-spatial parameters between CCS group and control group
CCS group (n = 12) Control group (self-selected speed)
(n = 20)
Control group (slow speed)
(n = 20)
Variable Units Mean DS Mean DS P value Mean DS P value
Speed m/s 0.72 ±0.25 1.28 ±0.11 0.000 0.71 ±0.08 0.835
Speed* %height 43.22 ±15.09 76.79 ±8.66 0.000 42.10 ±4.45 0.806
Stride Length* %height 58.20 ±11.67 80.24 ±4.26 0.000 61.62 ±4.35 0.345
Stride Time s 1.44 ±0.32 1.06 ±0.08 0.002 1.48 ±0.15 0.685
Strides/Minute 43.37 ±8.31 57.28 ±4.48 0.000 40.98 ±3.69 0.363
Step Length* %height 29.38 ±6.35 40.38 ±2.23 0.000 30.64 ±2.20 0.519
Step Time s 0.72 ±0.16 0.53 ±0.04 0.002 0.74 ±0.07 0.726
Cadence Steps/Minute 87.09 ±16.26 114.22 ±9.21 0.000 82.57 ±7.44 0.380
Single Support %cycle 0.44 ±0.05 0.38 ±0.02 0.000 0.45 ±0.04 0.494
Double Support %cycle 0.27 ±0.13 0.15 ±0.02 0.006 0.28 ±0.05 0.874
Percentage stance %cycle 68.41 ±4.58 63.99 ±1.19 0.007 69.20 ±1.81 0.573
Significant difference between conditions at P < 0.05.
*Height-corrected values.
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the gait cycle (Table 3).
c) Hip motion
The maximal hip flexion during stance was significantly
delayed in the group of CCS patients with respect to the
control group (Figure 3a) and these differences were larger
i nt h ef r o n t a lp l a n e( T a b l e4 ) .A tinitial contact, the patients
showed larger hip abduction, which reversed during the
course of the stance phase as at toe-off, the control subjects
showed larger hip abduction. Indeed, the CG subjects also
had a larger hip abduction during swing (Table 4).
The maximal hip adduction during stance occurred
earlier in the CG, while during swing the maximal hip
a d d u c t i o nw a sd e l a y e di nt h eC G( F i g u r e3 b ) .I nf a c t ,
the maximal hip abduction values during stance were
considerably delayed in the CG (Table 4).
d) Knee kinematics
The knee flexion at the initial contact was significantly
greater in the patients although the maximal flexion
during the stance phase was larger in the CG. However,
the minimal knee flexion during swing and stance were
l a r g e ri nt h eC C Sg r o u p ,w h i l ek n e ef l e x i o na tt o eo f f
was lower in CCS. It must be noted that the CG
reached a greater flexion during swing and they showed
higher knee ROM in the sagittal plane (Table 5). In
addition, the minimal knee flexion during swing was
reached earlier in the CG (Figure 3c).
e) Ankle kinematics
The minimal dorsi-flexion or maximal ankle plantar-
flexion during stance, at toe-off and during the swing
phase was smaller in the CCS group. Consequently, the
ankle flexo-extension ROM was higher in the CG.
The maximal value of the ankle plantar-flexion
occurred earlier in the CCS patients during stance but
not during swing (Figure 3d). Likewise, the instant of
minimal supination occurred earlier in the CCS group
(Table 6). However, the prono-supination ROM and the
maximal supination values were higher in the CG.
Discussion
The aim of this study was to objectively and quantita-
tively analyze and evaluate the gait of patients with CCS
using three-dimensional kinematic movement analysis
equipment, and to compare them with healthy subjects.
This comparison was made at both a self-selected speed
and at a matched speed in order to avoid any variation
due to velocity. The main findings of this study should
serve to define the basic rehabilitation strategies for
CCS patients.
The results of our study reveal that not only do
patients with CCS walk at a slower speed but also, that
they display a series of kinematic alterations such as a
smaller range of movement in the sagittal plane of the
knee, greater abduction of the hip at the initial contact
and during the oscillation phase, as well as a diminished
range of joint movement in the ankle.
Some of these kinematic findings coincide with the
data published elsewhere regarding the gait of patients
with incomplete SCI [18,19], such as the limited flexion
of the knee during the oscillation phase. Previously, the
Table 3 Pelvic kinematic parameters
CCS group (n = 12) Control Group (slow speed) (n = 20)
Variable Units Mean SD Mean SD P value
PELVIS TILT
Maximum degrees 20.26 ±8.09 20.46 ±4.39 0.939
Minimum degrees 13.66 ±7.371 15.14 ±4.87 0.544
Range of motion degrees 6.60 ±2.48 5.32 ±1.44 0.123
Time at max. pelvis tilt % cycle 48.17 ±10.50 38.52 ±16.20 0.076
Time at min. pelvis tilt % cycle 48.50 ±12.32 57.16 ±14.02 0.088
PELVIS OBLIQUITY
Maximum degrees 3.31 ±1.62 3.79 ±1.29 0.363
Minimum degrees -3.44 ±1.64 -4.13 ±1.31 0.200
Range of motion degrees 6.75 ±3.19 7.92 ±2.56 0.265
Time at max. pelvis obliquity % cycle 43.84 ±23.85 26.79 ±10.92 0.010
Time at min. pelvis obliquity % cycle 51.91 ±14.31 65.44 ±16.05 0.023
PELVIS ROTATION
Maximum degrees 5.75 ±2.07 4.66 ±1.18 0.067
Minimum degrees -6.00 ±2.49 -4.64 ±1.28 0.050
Range of motion degrees 11.74 ±4.47 9.30 ±2.28 0.049
Time at max. pelvis rotation % cycle 29.74 ±7.38 36.09 ±5.71 0.011
Time at min. pelvis rotation % cycle 64.98 ±14.82 66.87 ±13.72 0.716
Significant difference between conditions at P < 0.05.
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was explained by the antagonistic action of the rectus
femoris muscle and of the Vastus lateralis [18], leading
to the recommendation that strategies are adopted to
stretch these muscles or other such adaptations of clini-
cal treatments to improve these patients’ capacity to
walk. This limited flexion in our group of patients was
also evident, although we cannot confirm that it is due
to the antagonistic action of the quadriceps since we did
not register the electromyographic activity.
In our patients, the range of knee movement was
diminished in the sagittal plane, whereby the knee was
more flexed during the support phase and less flexed
than in the control group during the oscillation phase.
This reduced range of knee flexion has been observed in
other studies of patients with paraplegic-spastic gait of
diverse aetiology, in which this limitation was proposed
to be correlated with the degree of spasticity [5].
The degree of spasticity is mild in our sample of
patients, and they suffer no passive limitation to the
Figure 3 Mean kinematic features of CCS patients (dashed line, mean and standard deviation) compared with the control group
(continue thick line and grey line with standard deviation). The X-axis reflects the percentage of the gait cycle and on the Y-axis the units
are in degrees. Kinematic curve for hip flexion-extension (A), hip adduction-abduction (B), knee flexion-extension (C) and the ankle dorsi-plantar
flexion (D).
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due to a specific loss muscle control, as suggested pre-
viously[20].
The reduced joint movement of the knee and ankle in
the sagittal plane is not accompanied by a reduction in
the hip, as seen elsewhere [6]. The normal peak of plan-
tar flexion of the ankle is also diminished in patients
with CCS and as occurs in other neurological disorders,
this contributes to the reduced walking speed [21].
From a clinical point of view, the data obtained sug-
gest that in patients with CCS, we should preferentially
work on lengthening the ischiotibialis muscles and on
muscle coordination to try to reduce the knee flexion at
initial contact, and not only on strengthening the mus-
cles. Indeed, while some studies indicate that an increase
in strength in the lower limbs is related with an
improvement in gait [22], others consider that this is
not always the case [23].
Likewise, we also recommend stretching the anterior
rectus femoris and the Vastus lateralis to help increase
knee flexion during the oscillation phase and in general,
t oi m p r o v et h er a n g eo fk n e em o b i l i t yi nt h es a g i t t a l
plane [18].
One issue that cannot be overlooked is the walking
speed. It has been demonstrated that the speed at which
we walk conditions the kinematic variables of our gait
[13]. Our patients walk at a slower speed than the con-
trol group when walking at the self-selected speed, with
shorter strides and a lower cadence, while the double
support phase was longer. It has been reported that
decreasing gait speed might be useful to prevent a fall
when gait is perturbed [24,25].
Table 4 Hip kinematic parameters
CCS group (n = 12) Control Group (slow speed) (n = 20)
Variable Units Mean SD Mean SD P value
HIP FLEXION-EXTENSION
Flexion at initial contact degrees 40.20 ±9.11 38.68 ±6.41 0.584
Max. flex. in stance phase degrees 41.24 ±9.61 39.00 ±6.28 0.430
Min. flex. in stance phase degrees 4.14 ±8.69 4.15 ±6.41 0.998
Flexion at toe off degrees 17.60 ±10.17 17.92 ±6.39 0.913
Max. flex. in swing phase degrees 42.70 ±8.79 39.45 ±6.20 0.229
Min. flex. in swing phase degrees 17.45 ±9.96 17.92 ±6.39 0.870
Range of motion degrees 39.39 ±6.27 36.26 ±4.18 0.099
Time at max. flex. in stance phase % cycle 4.57 ±3.71 1.53 ±1.65 0.003
Time at min. flex. in stance phase % cycle 55.48 ±2.82 57.17 ±1.74 0.044
Time at flexion toe off % cycle 68.41 ±4.58 69.20 ±1.81 0.573
Time at max. flex. in swing phase % cycle 93.03 ±2.71 92.90 ±3.32 0.911
Time at min. flex. in swing phase % cycle 68.84 ±5.11 69.21 ±1.81 0.813
HIP ADDUCTIO-ABDUCTION
Abd. at initial contact degrees 4.44 ±2.61 2.56 ±2.30 0.041
Max. add. in stance phase degrees 3.99 ±2.69 3.30 ±2.32 0.451
Max. abd in stance phase degrees 6.83 ±2.77 7.63 ±1.92 0.339
Adduction at toe off degrees -4.36 ±3.61 -7.44 ±2.05 0.016
Max. add in swing phase degrees -0.57 ±2.54 -2.33 ±2.12 0.044
Max. abd in swing phase degrees 6.34 ±2.84 7.99 ±1.99 0.063
Range of motion degrees 12.20 ±3.25 11.42 ±2.68 0.471
Time at max. add in stance phase % cycle 41.94 ±11.35 30.26 ±11.97 0.011
Time at max. abd in stance phase % cycle 35.06 ±28.94 62.48 ±10.44 0.008
Time at max. add in swing phase % cycle 85.30 ±10.23 92.34 ±4.04 0.040
Time at max. abd in swing phase % cycle 80.28 ±7.85 72.36 ±4.26 0.006
HIP ROTATION
Maximum Internal rotation degrees 1.29 ±6.16 -0.486 ±6.59 0.455
Minimum internal rotation degrees -12.17 ±8.13 -12.58 ±6.83 0.880
Range of motion degrees 13.47 ±4.63 12.09 ±2.19 0.264
Time at max. internal rotation % cycle 51.03 ±14.98 49.77 ±25.03 0.859
Time at min. internal rotation % cycle 53.77 ±26.00 59.82 ±17.19 0.483
Significant difference between conditions at P < 0.05.
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CCS group (n = 12) Control Group (slow speed) (n = 20)
Variable Units Mean SD Mean SD P value
KNEE FLEXION
Flexion at initial contact degrees 14.20 ±5.50 4.03 ±3.02 0.000
Max. flex. in stance phase degrees 43.33 ±8.91 48.72 ±3.94 0.025
Min. flex. in stance phase degrees 6.72 ±6.60 2.87 ±3.21 0.034
Flexion at toe off degrees 44.25 ±8.94 49.73 ±3.92 0.023
Max. flex. in swing phase degrees 53.53 ±7.65 59.19 ±3.76 0,009
Min. flex. in swing phase degrees 12.67 ±6.37 2.89 ±3.44 0.000
Range of motion degrees 47.51 ±9.98 57.39 ±4.37 0.001
Time at max. flex. in stance phase % cycle 67.33 ±6.30 68.86 ±1.83 0.313
Time at min. flex. in stance phase % cycle 30.38 ±12.53 13.65 ±12.76 0.001
Time at max. flex. in swing phase % cycle 74.65 ±3.15 75.26 ±1.59 0.476
Time at min. flex. in swing phase % cycle 98.76 ±0.85 98.56 ±1.10 0.601
KNEE VARUS
Maximum degrees 3.69 ±3.62 5.06 ±2.38 0.204
Minimum degrees -6.43 ±6.68 -7.03 ±4.20 0.757
Range of motion degrees 10.13 ±4.18 12.10 ±3.98 0.193
Time at max. varus degrees 59.92 ±20.06 54.16 ±19.61 0.431
Time at min. varus degrees 56.91 ±18.76 70.17 ±9.22 0.012
KNEE ROTATION
Maximum internal rotation degrees 5.02 ±5.79 4.47 ±7.75 0.834
Minimum internal rotation degrees -8.56 ±5.22 -9.52 ±7.42 0.698
Range of motion degrees 13.58 ±2.83 13.99 ±2.77 0.690
Time at max. internal rotation % cycle 43.96 ±20.79 43.57 ±21.15 0.960
Time at min. internal rotation % cycle 72.64 ±13.10 73.85 ±13.87 0.808
Significant difference between conditions at P < 0.05.
Table 6 Ankle kinematic parameters
CCS group (n = 12) Control Group (slow speed) (n = 20)
Variable Units Mean SD Mean SD P value
ANKLE DORSIFLEXION
Dorsiflexion at initial contact degrees 3.29 ±4.90 3.13 ±3.15 0.912
Max. dorsi. in stance phase degrees 15.07 ±5.00 14.36 ±2.62 0.600
Min. dorsi. in stance phase degrees -7.91 ±4.98 -13.84 ±3.66 0.001
Dorsiflexion at toe off degrees -4.05 ±5.99 -12.98 ±4.14 0.000
Max. dorsi. In swing phase degrees 8.97 ±3.75 6.72 ±2.72 0.059
Min. dorsi. In swing phase degrees -4.99 ±5.67 -13.15 ±4.21 0.000
Range of motion degrees 23.52 ±6.10 28.50 ±3.58 0.007
Time at max. dorsi. in stance phase % cycle 47.98 ±5.13 48.44 ±2.97 0.749
Time at min. dorsi. in stance phase % cycle 36.18 ±20.75 62.63 ±13.97 0.000
Time at max. dorsi. in swing phase % cycle 87.54 ±3.36 89.20 ±4.34 0.265
Time at min. dorsi. in swing phase % cycle 74.68 ±10.09 69.43 ±1.86 0.029
ANKLE SUPINATION
Maximum degrees 8.94 ±9.77 15.55 ±5.42 0.019
Minimum degrees -15.59 ±7.79 -16.75 ±11.68 0.761
Range of motion degrees 24.53 ±6.16 32.30 ±11.66 0.041
Time at max. supination degrees 68.07 ±10.83 54.86 ±21.26 0.055
Time at min. supination degrees 52.00 ±16.47 63.57 ±11.64 0.027
Significant difference between conditions at P < 0.05.
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with different neurological diseases such as patients with
spastic paraplegia [26], cervical myelopathy [6] or Duch-
enne’s muscular dystrophy [11]. For this reason, the
subjects in the control group were also made to walk at
a similar speed as the group of patients with CCS. For
the control subjects to walk more slowly, they reduced
the length of their stride and their cadence, and they
increased the duration of the support phase, as demon-
strated in previous studies [13]. In this way, we ensured
that the speed did not influence the kinematic variables,
although we must also bear in mind that this may intro-
duce a certain bias in the data from the control group
since walking slowly may modify their normal gait.
Since there are many parameters that can be
obtained from gait analysis, it is necessary to take into
account the reliability of measurements in different
joint planes. In marker based gait analysis, some of
these parameters can be obtained with greater preci-
sion (hip and knee ROM in the sagittal plane) than
others (such as hip or knee rotation), since a larger
movement is measured.
There are certain limitations associated with this
study, the principal one being the lack of kinetic and
electromyographic data. Since we are aware of the
importance of such data, we have now introduced the
necessary modifications to our equipment so that these
parameters can be incorporated in future studies.
Despite this limitation, the data regarding gait has been
collected from the largest group of CCS patients yet stu-
died. To date, the only study of CCS patients published
using a three-dimensional analysis of movement to eval-
uate the kinematics of gait did not describe the pattern
obtained in these patients but rather, it compared these
CCS patients walking with the aid of one or two walking
sticks to evaluate the improvement in this population
[8]. Thus, there was no attempt to describe the kine-
matic differences with respect to a control group of sub-
jects. Hence, we consider that our data represents the
first attempt to define the alterations in joint movement
associated with this type of disorder, which should help
improve the strategies adopted in rehabilitation
therapies.
We believe it is difficult to perform studies on this
type of population given that there is still no clear
consensus regarding the diagnostic criteria. However, a
recent review concluded [27] established that the exis-
tence of a difference of at least 10 points between the
m o t o ri n d e xo fu p p e ra n dl o w e rl i m b ss e r v e da sa
good diagnostic criterion for CCS [27]. In our cohort,
the mean difference in the motor index of upper and
lower limbs was 8.5 points. Although we are aware
that this does not reach the minimum threshold of 10
points, the difference is small and as such, the results
presented here are likely to be relevant. Nevertheless,
the small difference in the motor index found leads us
to assume that our group of patients suffer a mild
form of CCS.
Conclusion
CCS patients experience a decrease of knee and ankle
sagittal motion during level walking and an increase of
hip abduction. The reduction in the range of motion of
these joints cannot be attributed to increased spasticity
but rather to other compensatory mechanisms aimed at
improving gait stability, and to the neural damage suf-
fered by the patients.
The findings of this study help to improve the under-
standing how CCS affects gait changes in the lower
limbs and how to design rehabilitation strategies for
their treatment.
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